Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 90096-151

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 90096-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zameer Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1000 mg (Image 3)

Ranolazine Extended-Release Tablets 1000 mg film-coated, extended-release oral tablets. The label indicates 60 tablets per package, produced by Zameer Pharmaceuticals LLC. Storage instructions, manufacturer details, and warnings for child-resistant packaging are also visible on the label.*

FDA Label Image

Structure (Image 01)

Chemical structure of ranolazine showing its molecular arrangement with amide, amine, ether, hydroxyl, and methoxy functional groups represented by their bonded atoms and bonds.*

FDA Label Image

Label 500 mg (R500mg)

Ranolazine Extended-Release Tablets 500 mg film-coated tablets label from Zameer Pharmaceuticals LLC. The label includes NDC 90096-151-60, storage instructions at 25°C with permitted excursions, manufacturer and distributor details, and a warning to keep medication out of children’s reach. The package contains 60 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.